USD92.58 ₽ EUR100.28 ₽ telegram Telegram
2024-03-21 обновлены отчеты компании CYCC: 20232022
Cyclacel Pharmaceuticals logo
Cyclacel Pharmaceuticals CYCC
$ 1.51 -5.63%

Cyclacel Pharmaceuticals Мультипликаторы 2011-2024 | CYCC

Мультипликаторы по годам Cyclacel Pharmaceuticals

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

P/E

-0.1 -0.0 -1.5 -4.1 -1.5 -1.3 -1.8 -1.4 -0.8 -0.7 -5.4 -3.1 -1.9

P/S

5.5 - - 5899.1 - 63.7 - 19.3 6.0 7.3 50.8 594.7 41.0

EPS

- - -2.1 -3.4 -0.5 -0.6 -1.9 -3.5 -0.5 -0.9 -1.3 -1.7 -0.3

EV (Enterprise Value)

7.13 млн -10.3 млн -2.22 млн 4.81 млн 3.15 млн -3.4 млн -6.55 млн 5.17 млн -2.79 млн -3.76 млн 31.4 млн 34 млн 10.7 млн

EBITDA per Share

-24 -44 -2.56 -2.15 -11.8 -15.7 -24.8 -81.9 -118 -243 -283 -502 -539

EV/EBITDA

0.2 -0.1 0.0 0.8 1.1 0.0 0.5 0.5 -1.3 -1.6 -0.3

PEG

-0.0 -0.0 0.04 -0.06 -0.07 -0.02 -0.04 -0.04 -0.02 -0.02 -0.13 -3.48 -0.05

P/B

3.8 0.0 0.8 1.0 1.0 0.6 0.6 1.1 0.6 0.6 2.0 4.1 1.5

P/CF

-0.1 -0.0 -1.6 -4.3 -1.2 -1.4 -1.8 -1.6 -0.8 -0.7 -3.0 -3.4 -2.1

ROE %

-3715.82 -132.99 -50.69 -25.39 -66.94 -47.72 -34.32 -82.61 -76.15 -89.39 -36.23 -131.61 -78.17

ROA %

-256.16 -75.57 -44.35 -22.95 -51.15 -36.77 -28.73 -59.97 -57.91 -65.97 -28.58 -68.13 -58.63

ROCE %

-4193.25 -173.51 -61.56 -30.99 -75.12 -62.11 -43.36 -98.24 -85.06 -102.48 -64.14 -150.74 -84.04

Current Ratio

1.1 3.7 8.0 14.3 5.8 4.4 6.3 3.7 4.3 3.9 4.7 2.0 4.0

DSO

- - - 81545.9 - 3659.7 - 890.6 568.2 728.3 - - -

DIO

- - - - - - - - - - - - 184.5

DPO

- - - - - - - - - - - - 1787.5

Операционный цикл

- - - - - - - - - - - - 184.5

Финансовый цикл

- - - - - - - - - - - - -1603.0

Все данные представлены в валюте USD

Мультипликаторы поквартально Cyclacel Pharmaceuticals

2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

EPS

-0.44 -0.47 - -0.42 -0.46 -0.42 - -0.54 -0.56 -0.5 - -0.47 -0.58 -1.48 - -2.27 -2.13 -2.77 - -0.18 -0.16 -0.12 - -0.91 -0.5 -0.38 - -0.86 -1.01 -1.04 - -0.95 -1.19 -0.19 - -0.22 -0.22 -0.25 - -0.32 0.1 -1.18 - -0.25 -0.45 -0.4 - -0.07 -0.08 -0.1

EBITDA per Share

- -0.58 - -0.52 -0.57 -0.66 - -0.64 -0.66 -0.61 - -0.53 -0.64 -2.81 - -2.71 -2.71 -3.22 - -0.2 -0.2 -0.18 - -0.21 -0.56 -0.63 - -0.97 -1.23 -1.25 - -1.12 -1.23 -0.2 - -0.24 -0.24 -0.28 - -0.32 -0.3 -0.41 - -0.41 -0.45 -0.4 - -0.47 -0.08 -0.1

ROE %

-209.45 -118.53 -50.53 -62.59 -51.55 -48.27 -31.16 -37.94 -32.67 -27.32 -16.96 -33.22 -42.68 -51.42 -47.24 -60.78 -58.07 -54.96 -34.50 -43.03 -38.02 -35.94 -25.72 -46.36 -58.47 -69.20 -62.72 -77.10 -70.85 -67.84 -58.23 -80.86 -89.10 -93.52 -67.26 -85.12 -80.35 -52.84 -23.53 -42.39 -43.40 -84.43 -84.06 -101.73 -100.53 -83.04 -59.41 -17.67 -18.22 -23.53

ROA %

-92.30 -72.11 -39.74 -50.82 -45.47 -43.60 -28.86 -34.99 -30.04 -24.86 -15.33 -27.75 -34.04 -39.80 -36.10 -46.53 -44.55 -42.25 -26.58 -33.72 -30.43 -29.49 -21.53 -36.52 -44.36 -51.03 -45.53 -56.47 -52.42 -50.86 -44.29 -60.99 -66.75 -69.61 -49.64 -63.73 -61.12 -40.54 -18.56 -28.33 -24.01 -46.69 -43.52 -56.77 -60.25 -55.43 -44.56 -13.25 -13.66 -17.65

ROCE %

-246.18 -149.89 -68.09 -82.59 -67.78 -62.75 -37.57 -45.31 -38.54 -31.86 -22.45 -42.53 -54.87 -67.41 -58.90 -74.97 -70.97 -67.13 -46.37 -56.08 -49.70 -45.00 -33.51 -57.87 -72.53 -87.44 -76.94 -94.96 -88.61 -81.47 -65.35 -91.50 -99.62 -106.12 -76.79 -97.47 -92.01 -81.13 -49.96 -85.11 -99.59 -122.81 -104.29 -124.19 -108.93 -90.36 -63.98 -19.90 -19.47 -24.62

Current Ratio

2.4 3.0 3.7 7.0 6.9 6.4 8.0 12.4 14.9 13.8 10.4 10.4 10.4 10.4 4.2 4.2 4.2 4.2 4.4 4.4 4.4 4.4 6.1 6.1 6.1 6.1 3.6 3.6 3.6 3.6 4.2 4.2 4.2 4.2 3.8 3.8 3.8 3.8 4.7 4.7 4.7 4.7 2.1 2.1 2.1 2.1 4.0 4.0 4.0 4.0

DSO

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - 3.3 - - - - - - - - - - - - - 54.0 79.0 32.9 - - - -

DIO

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

DPO

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Операционный цикл

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - 3.3 - - - - - - - - - - - - - 54.0 79.0 32.9 - - - -

Финансовый цикл

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - 3.3 - - - - - - - - - - - - - 54.0 79.0 32.9 - - - -

Все данные представлены в валюте USD